A Phase 1, 2-Panel, Open-Label, Fixed-Sequence Study in Healthy Adult Subjects to Investigate the Pharmacokinetic Interaction Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2017
At a glance
- Drugs JNJ 54861911 (Primary) ; Metformin; Rosuvastatin
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 22 Aug 2016 Status changed from recruiting to completed.
- 21 Apr 2016 Status changed from not yet recruiting to recruiting.
- 21 Mar 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016, as reported by ClinicalTrials.gov.